Pan Jianping, Zhang Minghui, Wang Jianli, Wang Qingqing, Xia Dajing, Sun Wenji, Zhang Lihuang, Yu Hai, Liu Yongjun, Cao Xuetao
Institute of Immunology, Zhejiang University, Hangzhou 310031, PR China.
Immunol Lett. 2004 Jun 15;94(1-2):141-51. doi: 10.1016/j.imlet.2004.05.003.
Maturation of dendritic cells (DC) is critical for efficient antigen presentation and initiation of an immune response. Interferon-gamma (IFN-gamma) is an important Th1 cytokine. In this study, we investigated the role of IFN-gamma in DC maturation using either IFN-gamma receptor deficient- or IFN-gamma overexpression-models. We showed that immature DC generated in vitro from bone marrow (BM) progenitor cells produced low level of IFN-gamma. After LPS stimulation, DC produced more IFN-gamma, and IFN-gamma productions were at comparable levels among C57BL/6 mice-derived DC (C57BL/6 DC), wild-type 129 mice-derived DC (129 DC) and IFN-gamma receptor deficient 129 mice-derived DC (IFN-gammaR-/-DC). We found that IFN-gammaR-/-DC exhibited decreased expression of CD54, CD86, reduced capacity to secrete IL-1beta and IL-12p70, and impaired capacity to stimulate alloreactive T cells and to drive Th1 differentiation. Transfection of IFN-gamma gene into DC promoted DC to express higher CD40, CD54, CD80, CD86, CCR7 and I-Ab, secrete more IL-1beta and IL-12p70, and more potently activate both CD4 and CD8 T cells. These data suggest that IFN-gamma signaling pathway is important for the maturation of DC in an autocrine fashion.
树突状细胞(DC)的成熟对于有效的抗原呈递和免疫反应的启动至关重要。干扰素-γ(IFN-γ)是一种重要的Th1细胞因子。在本研究中,我们使用IFN-γ受体缺陷型或IFN-γ过表达模型研究了IFN-γ在DC成熟中的作用。我们发现,从骨髓(BM)祖细胞体外生成的未成熟DC产生低水平的IFN-γ。LPS刺激后,DC产生更多的IFN-γ,并且在C57BL/6小鼠来源的DC(C57BL/6 DC)、野生型129小鼠来源的DC(129 DC)和IFN-γ受体缺陷的129小鼠来源的DC(IFN-γR-/-DC)中,IFN-γ的产生水平相当。我们发现,IFN-γR-/-DC表现出CD54、CD86表达降低,分泌IL-1β和IL-12p70的能力降低,刺激同种异体反应性T细胞和驱动Th1分化的能力受损。将IFN-γ基因转染到DC中可促进DC表达更高水平的CD40、CD54、CD80、CD86、CCR7和I-Ab,分泌更多的IL-1β和IL-12p70,并更有效地激活CD4和CD8 T细胞。这些数据表明,IFN-γ信号通路以自分泌方式对DC的成熟很重要。
Immunol Lett. 2004-6-15
Eur J Immunol. 1997-5
Int Immunopharmacol. 2007-6
Eur J Immunol. 1997-7
J Exp Clin Cancer Res. 2025-4-10
Cell Rep. 2025-2-25
Front Vet Sci. 2024-6-19
Vaccines (Basel). 2024-4-29
Cell Commun Signal. 2024-5-7